Eli Lilly's GLP-1 Impact on ResMed Is Overblown: Barron's

Seeking Alpha15:34 ET

Morgan Stanley Sees $180B Patent Cliff, $380B Deal Capacity Fueling Biopharma M&A

Seeking Alpha14:03 ET

Financial Stocks Deliver Profits in Q2 Amid Rebound in Investments - Earnings Scorecard

Seeking AlphaJul 13 10:47 ET

Lilly Expecting Q2 IPR&D Pre-tax Charge of Around $0.14 per Share: Report

Seeking AlphaJul 12 16:55 ET

These Are the Stocks With the Highest Increase in Short Interest Within Life Sciences and Diagnostics - Baird

Seeking AlphaJul 12 14:30 ET

Looking At Thermo Fisher Scientific's Recent Unusual Options Activity

Financial giants have made a conspicuous bearish move on Thermo Fisher Scientific. Our analysis of options history for Thermo Fisher Scientific (NYSE:TMO) revealed 9 unusual trades.Delving into the

BenzingaJul 12 13:31 ET